Apollo Medical Holdings, Inc. (NASDAQ:AMEH – Get Rating) gapped down before the market opened on Thursday . The stock had previously closed at $35.80, but opened at $33.69. Apollo Medical shares last traded at $33.45, with a volume of 722 shares trading hands.
A number of brokerages have recently commented on AMEH. Colliers Securities reaffirmed a “buy” rating on shares of Apollo Medical in a research report on Tuesday, March 22nd. TheStreet lowered Apollo Medical from a “b-” rating to a “c+” rating in a research report on Monday, March 7th.
The stock has a 50 day simple moving average of $37.31 and a 200-day simple moving average of $50.81. The firm has a market cap of $1.90 billion, a PE ratio of 21.96 and a beta of 0.56. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.77 and a quick ratio of 2.77.
A number of large investors have recently made changes to their positions in AMEH. Wells Fargo & Company MN grew its stake in Apollo Medical by 45.9% in the second quarter. Wells Fargo & Company MN now owns 33,426 shares of the company’s stock worth $2,099,000 after purchasing an additional 10,510 shares in the last quarter. Morgan Stanley lifted its holdings in Apollo Medical by 148.4% during the second quarter. Morgan Stanley now owns 97,894 shares of the company’s stock worth $6,149,000 after buying an additional 58,490 shares during the period. Credit Suisse AG lifted its holdings in Apollo Medical by 9.5% during the third quarter. Credit Suisse AG now owns 28,327 shares of the company’s stock worth $2,579,000 after buying an additional 2,463 shares during the period. Macquarie Group Ltd. purchased a new stake in Apollo Medical during the third quarter worth $47,000. Finally, Hsbc Holdings PLC purchased a new stake in Apollo Medical during the third quarter worth $384,000. 30.81% of the stock is currently owned by institutional investors.
Apollo Medical Company Profile (NASDAQ:AMEH)
Apollo Medical Holdings, Inc, a physician-centric technology-powered healthcare company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
Featured Stories
- Get a free copy of the StockNews.com research report on Apollo Medical (AMEH)
- The Q2 Earnings Season Could Be A Bloodbath
- Commercial Metals Company Is Ready To Rebound
- The Institutions Turn The Tide For Jabil
- A10 Networks: Key 5G Infrastructure Stock that’s Beating the Market
- Allstate: A Safe Stock During Volatile Times, Which Will Benefit From Rising Rates
Want More Great Investing Ideas?
- Bear Market Game Plan!
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 3 Stocks to DOUBLE This Year
Receive News & Ratings for Apollo Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollo Medical and related companies with MarketBeat.com's FREE daily email newsletter.